Affinity of (±)-pindolol, (-)-penbutolol, and (-)-tertatolol for pre- and postsynaptic serotonin 5-HT(1A) receptors in human and rat brain

Journal of Neurochemistry

Volumn 75, Issue 2, 2000, Pages 755-762

  Castro, M E ^a   Harrison, P J ^b   Pazos, A ^c   Sharp, T ^a,d  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b WARNEFORD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adrenoceptors; 3H WAY 100635; Penbutolol; Pindolol; Serotonin 5 HT(1A) receptors; Tertatolol

Indexed keywords

BETA ADRENERGIC RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PENBUTOLOL; PINDOLOL; SEROTONIN 1A RECEPTOR; TERTATOLOL; ANTIARRHYTHMIC AGENT; PIPERAZINE DERIVATIVE; PRESYNAPTIC RECEPTOR; PROPANOLAMINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; THIOPHENE DERIVATIVE; TRITIUM;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SEROTONINERGIC SYSTEM; AGED; ANIMAL; AUTORADIOGRAPHY; DENTATE GYRUS; FEMALE; METABOLISM; RADIOASSAY; RAPHE NUCLEUS; SPRAGUE DAWLEY RAT; SYNAPSE;

AGED; ANIMALS; ANTI-ARRHYTHMIA AGENTS; AUTORADIOGRAPHY; BRAIN; DENTATE GYRUS; FEMALE; HIPPOCAMPUS; HUMANS; MALE; PENBUTOLOL; PINDOLOL; PIPERAZINES; PROPANOLAMINES; PYRIDINES; RADIOLIGAND ASSAY; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PRESYNAPTIC; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS; SYNAPSES; THIOPHENES; TRITIUM;

EID: 0033623795     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750755.x     Document Type: Article

References (41)

1. Artigas F., Péz V., and Alvarez E. (1994) Pindolol induces a rapid improvement of patients with depression treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry 51, 248-251.
2. Åsberg M., Erikson B., Matenson B., Traskman-Bendz L., and Warner A. (1986) Therapeutic effects of serotonin uptake inhibitors in depression. J. Clin. Psychiatry 47, 23-25.
3. Auerbach S. B., Lundberg J. F., and Hjorth S. (1995) Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology 34, 89-96.
4. Berman R. M., Darnell A. M., Miller H. L., Anand A., and Charney D. S. (1997) Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double blind, placebo controlled trial. Am. J. Psychiatry 154, 37-43.
5. Blier P. and Bergeron R. (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol. 15, 217-222.
6. Blier P. and De Montigny C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220-226.
7. Boddeke H. W. G. M., Fargin A., Raymond J. R., Schoeffter P., and Hoyer D. (1992) Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells. Naunyn Schmeidebergs Arch. Pharmacol. 345, 257-263.
8. 3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem. Int. 30, 565-574.
9. 1A receptors in rat brain. Br. J. Pharmacol. 126, 260P.
10. 1A antagonist on forebrain expression of the immediate early gene ARC. Br. J. Pharmacol. 128, 165P.
11. Chaput Y., Blier P., and De Montigny C. (1986) In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J. Neurosci. 6, 2796-2801.
12. 1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats. Neuropharmacology 30, 711-717.
13. 1A autoreceptor in vivo. Br. J. Pharmacol. 124, 206-212.
14. Clifford E. M., Whale R., Sharp T., and Cowen P. (1999) Effect of penbutolol on neuroendocrine responses to buspirone and mood in SSRI-refractory patients: a preliminary study. Hum. Psychopharmacol. 14, 273-277.
15. 1A receptors in the rat brain. Br. J. Pharmacol 123, 449-462.
16. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology (Berl.) 121, 1-26.
17. Fornal C. A., Martín F. J., Mendlin A., Metzler C. W., Bjorvatn B., and Jacobs B. L. (1999) Pindolol increases extracellular 5-HT while inhibiting serotonergic neuronal activity. Eur. J. Pharmacol. 377, 187-191.
18. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115, 1064-1070.
19. Gartside S. E., Clifford E. M., Cowen P. J., and Sharp T. (1999) Effects of (-)-tertatolol, (-)-penbutolol and (±)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. Br. J. Pharmacol. 127, 145-152.
20. Hajós M., Gartside S. E., and Sharp T. (1995) Inhibition of median and dorsal raphé neurones by the selective 5-HT reuptake inhibitor paroxetine. Naunyn Schmiedebergs Arch. Pharmacol. 351, 624-629.
21. 1A receptors measured in vivo using small animal positron emission tomography with carbon-11 labelled WAY-100635. Synapse 36, 330-341.
22. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem. 60, 776-779.
23. 1A (auto)receptor-mediated decrease of 5-HT release in the rat brain in vivo. Fourth IUPHAR Satellite Meeting on Serotonin, Rotterdam, July 23-25.
24. Hjorth S. and Carlsson A. (1986) Is pindolol a mixed agonist, antagonist at central serotonin (5-HT) receptors? Eur. J. Pharmacol. 129, 131-138.
25. Hjorth S. and Sharp T. (1993) In vivo microdialysis evidence for central serotonin 1A and serotonin 1B autoreceptor blocking properties of the beta-adrenoceptor antagonist (-)penbutolol. J. Pharmacol. Exp. Ther. 265, 707-712.
26. Hoyer D. and Schoeffter P. (1991) 5-HT receptors: subtypes and second messengers. J. Recept. Res. 11, 197-214.
27. 3H]ketanserin. Eur. J. Pharmacol. 118, 13-23.
28. 1A receptors in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 347, 453-463.
29. 1A receptor antagonist. Brain Res. 673, 217-225.
30. 1A receptor antagonist, to rat brain. J. Neurochem. 64, 2716-2726.
31. 1B receptors. Eur. J. Pharmacol. 244, 77-87.
32. McAskill R., Mir S., and Taylor D. (1998) Pindolol augmentation of antidepressant therapy. Br. J. Pharmacol. 173, 203-208.
33. 1A) receptors. Neuropsychopharmacology 18, 395-398.
34. 35S]GTPgammaS binding by 5-HT receptor agonist in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state. Naunyn Schmiedebergs Arch. Pharmacol. 356, 551-561.
35. Pérez V., Gilaberte I., Faries D., Alvarez E., and Artigas F. (1997) Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 349, 1594-1597.
36. Pérez V., Soler J., Puigdemont D., Alvarez E., and Artigas F. (1999) A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Arch. Gen. Psychiatry 56, 375-379.
37. 1A) receptor antagonist in rat brain. J. Pharmacol. Exp. Ther. 265, 739-744.
38. 1A receptors in vivo and in vitro: implications for antidepressant therapy. Neuropsychopharmacology (in press).
39. 1A receptor ligands to pre-and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain. Synapse 34, 68-76.
40. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15, 349-360.
41. 1A agonists measured with the forced swim test. Psychopharmacology (Berl.) 101, 497-504.